Phenytoin and Temodar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phenytoin (phenytoin) and Temodar (temozolomide). Common drug interactions include thrombocytopenia among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Phenytoin and Temodar. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Phenytoin?

Phenytoin has active ingredients of phenytoin. It is often used in epilepsy. eHealthMe is studying from 15,753 Phenytoin users. Check the latest studies of Phenytoin.

What is Temodar?

Temodar has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 6,683 Temodar users. Check the latest studies of Temodar.



On Jul, 08, 2026

26 people who take Phenytoin and Temodar together, and have interactions are studied.

Phenytoin and Temodar drug interactions.

What are the common drug interactions of Phenytoin and Temodar, by gender? *:

female:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Alanine aminotransferase decreased
  3. Aspartate aminotransferase decreased
  4. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  5. Haemoglobin decreased
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  3. Fatigue (feeling of tiredness)
  4. Oedema (fluid collection in tissue)
  5. Pruritus (severe itching of the skin)
  6. Sedation
  7. Insomnia (sleeplessness)
  8. Vomiting
  9. Anticonvulsant drug level increased
  10. Apraxia (disorder that affects a person's ability to organize the movements of the muscles used in speech)

What are the common drug interactions of Phenytoin and Temodar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  2. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Face oedema (swelling of face)
  5. Fatigue (feeling of tiredness)
  6. Nausea (feeling of having an urge to vomit)
  7. Oedema (fluid collection in tissue)
  8. Pruritus (severe itching of the skin)
  9. Pyrexia (fever)
  10. Sedation

40-49:

n/a

50-59:

  1. Blood potassium decreased
  2. Blood pressure inadequately controlled
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Epistaxis (bleed from the nose)
  5. Fall
  6. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  7. Haematemesis (vomiting of blood)
  8. Haemorrhage intracranial (bleeding within the skull)
  9. Hemiparesis (weakness on one side of the body)
  10. Hydrocephalus (water on the brain)

60+:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Disease progression
  3. Anaemia (lack of blood)
  4. Aphasia (damage to the parts of the brain that control language)
  5. Apraxia (disorder that affects a person's ability to organize the movements of the muscles used in speech)
  6. Asthenia (weakness)
  7. Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
  8. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Chest pain

What are the existing conditions these people have? *

  1. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 4 people, 15.38%
  2. Brain Neoplasm (tumour of brain): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Phenytoin and Temodar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phenytoin and Temodar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phenytoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Temodar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenytoin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temodar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on phenytoin and temozolomide (the active ingredients of Phenytoin and Temodar, respectively), and Phenytoin and Temodar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: